A study by a multidisciplinary team at Weill Cornell Medicine has identified a new protein variant that underlies the ability of gastric cancers to resist an otherwise effective family of chemotherapy drugs.
A new protein variant underlies the ability of gastric cancers to resist an otherwise effective family of chemotherapy drugs, according to a study by a multidisciplinary team at Weill Cornell Medicine. The results suggest a treatment strategy that could improve the prognoses of many patients with cancer.
A study by a multidisciplinary team at Weill Cornell Medicine has identified a new protein variant that underlies the ability of gastric cancers to resist an ot
Study identifies master regulator behind the development of antibody-producing cells news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
Antibody-Producing B Cells May be Predestined for their Fates cornell.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cornell.edu Daily Mail and Mail on Sunday newspapers.